|
|
|
|
Document Preview AVI Biopharma Announces Termination of Merger Agreement; Exchange Offer with Exegenics, Inc. |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
AVI Biopharma Announces Termination of Merger Agreement; Exchange Offer with Exegenics, Inc. |
|||
|
Entities: |
AVI BioPharma, Inc.; eXegenics Inc.; Mellon Investor Services LLC |
|||
|
Date: |
2003 |
|||
|
Size: |
Preview shows 1KB of 4KB total |
|||
|
Price: |
$39 |
|||
|
ID: |
#286898 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
Filed by AVI BioPharma, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
Subject Company: eXegenics, Inc.
Commission File No. 0-26648
AVI Contact:
AVI BioPharma, Inc.
Michael Hubbard (hubbard@avibio.com)
(503) 227-0554
Investor Contacts:
Lippert/Heilshorn & Associates Inc.
Bruce Voss (bvoss@lhai.com)
Jody Cain (jcain@lhai.com)
(310) 691-7100
Press Contact:
Waggener Edstrom Bioscience
Wendy Carhart (wendyc@wagged.com)
(503) 443-7000
End
of Preview
Home
Intelligence
Services
Subscriptions
News
About Us
AVI BioPharma Announces Termination of Merger Agreement; Exchange Offer With eXegenics, Inc.